non-varix upper gastrointestinal tract bleeding
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Subjects obtained written informed consent 2) Subjects taking antithrombotic drug for more than 1 month 3) Subjects who had a diagnosis of upper gastrointestinal tract bleeding with esophagogastroduodenoscopy
Exclusion criteria
Exclusion criteria: bleeding from varix
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Re-bleeding rate | — |
Secondary
| Measure | Time frame |
|---|---|
| number of times of hemostasis, fast period, length of stay, quantity of total blood transfusion | — |
Countries
Japan
Contacts
Gifu University Hospital Gastroenterology